{
  "version": "2026",
  "questionId": "MISSION-500-169-1771352128657",
  "itemType": "standalone_highlight",
  "difficulty": 5,
  "nclexClientNeed": "Safety and Infection Control",
  "integratedProcesses": [
    "Clinical Judgment",
    "Nursing Process: Assessment",
    "Nursing Process: Implementation"
  ],
  "cognitiveLevel": "Analyze",
  "keywords": [
    "serotonin syndrome",
    "contraindication",
    "safety",
    "sertraline",
    "sumatriptan",
    "highlight",
    "ngn",
    "medication safety"
  ],
  "contentArea": "Mental Health",
  "caseData": {
    "patient": {
      "id": "CASE-500-A771",
      "age": "54",
      "gender": "Male",
      "setting": "Medical-Surgical Unit"
    },
    "tabs": [
      {
        "id": "nurses_notes",
        "label": "Nurses' Notes",
        "content": "<b>0800:</b> 54-year-old male admitted from the ED with altered mental status. Patient is exhibiting significant agitation and confusion, attempting to climb out of bed. He is diaphoretic, shivering, and has hyperactive reflexes (+4) with pronounced involuntary jerking movements of his lower legs when ankles are dorsiflexed. His wife reports he has a history of major depressive disorder and hypertension. She also states he lives in a rural community with limited primary care access and was recently started on a new medication for migraines via a telehealth visit two days ago. Denies illicit drug use."
      },
      {
        "id": "vital_signs",
        "label": "Vital Signs",
        "type": "table",
        "data": [
          {
            "Time": "ED Arrival (T0)",
            "Temp": "37.9° C (100.2° F)",
            "HR": "110",
            "BP": "155/95",
            "RR": "22",
            "SpO2": "96% RA"
          },
          {
            "Time": "Unit Arrival (T+2h)",
            "Temp": "38.5° C (101.3° F)",
            "HR": "125",
            "BP": "168/100",
            "RR": "24",
            "SpO2": "95% RA"
          },
          {
            "Time": "Current (T+4h)",
            "Temp": "39.4° C (102.9° F)",
            "HR": "140",
            "BP": "180/105",
            "RR": "28",
            "SpO2": "93% RA"
          }
        ]
      },
      {
        "id": "labs",
        "label": "Laboratory Results",
        "type": "table",
        "data": [
          {
            "Test": "WBC",
            "Value": "12.5 x 10³/μL",
            "Reference Range": "4.5-11.0"
          },
          {
            "Test": "Potassium",
            "Value": "5.2 mEq/L",
            "Reference Range": "3.5-5.0"
          },
          {
            "Test": "BUN",
            "Value": "28 mg/dL",
            "Reference Range": "7-20"
          },
          {
            "Test": "Creatinine",
            "Value": "1.5 mg/dL",
            "Reference Range": "0.6-1.2"
          },
          {
            "Test": "Creatine Kinase (CK)",
            "Value": "5,800 U/L",
            "Reference Range": "30-220"
          }
        ]
      },
      {
        "id": "mar",
        "label": "Medication Administration Record",
        "type": "table",
        "data": [
          {
            "Medication": "Sertraline 100 mg PO",
            "Route": "PO",
            "Frequency": "Daily",
            "Time Due": "0900",
            "Notes": "Scheduled - Due Now"
          },
          {
            "Medication": "Sumatriptan 50 mg PO",
            "Route": "PO",
            "Frequency": "PRN Migraine",
            "Time Due": "0430",
            "Notes": "Administered in ED at 0430"
          },
          {
            "Medication": "Ondansetron 4 mg IV",
            "Route": "IV",
            "Frequency": "PRN Nausea",
            "Time Due": "0700",
            "Notes": "Administered on unit at 0700"
          },
          {
            "Medication": "Lorazepam 2 mg IV",
            "Route": "IV",
            "Frequency": "PRN Agitation",
            "Time Due": "PRN",
            "Notes": "Available"
          }
        ]
      }
    ]
  },
  "question": {
    "type": "m_highlight",
    "prompt": "The nurse is reviewing the client's record before administering the 0900 medications. Click to highlight the findings in the Nurses' Notes that indicate an immediate need to withhold the scheduled sertraline and contact the healthcare provider.",
    "textToSelect": "<b>0800:</b> 54-year-old male admitted from the ED with altered mental status. Patient is exhibiting significant agitation and confusion, attempting to climb out of bed. He is diaphoretic, shivering, and has hyperactive reflexes (+4) with pronounced involuntary jerking movements of his lower legs when ankles are dorsiflexed. His wife reports he has a history of major depressive disorder and hypertension. She also states he lives in a rural community with limited primary care access and was recently started on a new medication for migraines via a telehealth visit two days ago. Denies illicit drug use.",
    "allowMultiple": true,
    "correctAnswers": [
      "agitation and confusion",
      "diaphoretic, shivering, and has hyperactive reflexes (+4)",
      "involuntary jerking movements of his lower legs when ankles are dorsiflexed"
    ],
    "answerBreakdown": {
      "itemRationale": "The client is exhibiting signs and symptoms indicative of serotonin syndrome, a potentially life-threatening condition resulting from excessive serotonergic activity in the central nervous system (CNS) and peripheral nervous system. This syndrome is often triggered by the combination of multiple serotonergic medications. In this case, the patient is taking sertraline (SSRI), sumatriptan (triptan), and ondansetron (5-HT3 receptor antagonist), all of which can increase serotonin levels. The classic clinical triad of serotonin syndrome includes: 1) altered mental status (agitation, confusion), 2) autonomic instability (diaphoresis, shivering, hyperthermia, tachycardia, hypertension), and 3) neuromuscular hyperactivity (hyperreflexia, clonus). The nurse must recognize these critical findings, withhold the scheduled sertraline dose (a 'safety stop' action), and immediately notify the healthcare provider to initiate emergency treatment, which may include discontinuing serotonergic medications, administering supportive care (e.g., cooling measures, IV fluids), and administering medications such as cyproheptadine (a serotonin antagonist). Failure to recognize and act on these findings could lead to severe complications, including hyperthermia, seizures, rhabdomyolysis, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and death.",
      "optionRationale": [
        {
          "option": "agitation and confusion",
          "rationale": "CORRECT: This describes altered mental status, a core component of the serotonin syndrome triad. Serotonin syndrome leads to overstimulation of the CNS, causing changes in mental status ranging from mild anxiety to severe delirium. This finding is a critical indicator of CNS toxicity and necessitates immediate intervention.",
          "isCorrect": true,
          "score": 1
        },
        {
          "option": "diaphoretic, shivering, and has hyperactive reflexes (+4)",
          "rationale": "CORRECT: This phrase captures two key components of serotonin syndrome: autonomic instability (diaphoresis, shivering) and neuromuscular hyperactivity (hyperreflexia). Autonomic instability results from excessive serotonin affecting the hypothalamus and brainstem, leading to dysregulation of vital functions. Hyperreflexia is a sign of increased spinal cord excitability due to serotonin excess. These are cardinal signs of the toxic state and require immediate attention.",
          "isCorrect": true,
          "score": 1
        },
        {
          "option": "involuntary jerking movements of his lower legs when ankles are dorsiflexed",
          "rationale": "CORRECT: This is a classic description of clonus, a hallmark sign of neuromuscular excitation central to the diagnosis of serotonin syndrome. Clonus is characterized by rhythmic, involuntary muscle contractions and relaxations, indicating significant nervous system irritability and excessive serotonin activity in the spinal cord.",
          "isCorrect": true,
          "score": 1
        },
        {
          "option": "54-year-old male admitted from the ED with altered mental status.",
          "rationale": "INCORRECT: While 'altered mental status' is relevant, this phrase primarily includes demographic data and location, which are context, not the specific clinical signs that signal the immediate danger. Highlighting only this phrase would miss the critical autonomic and neuromuscular signs.",
          "isCorrect": false,
          "score": 0
        },
        {
          "option": "history of major depressive disorder and hypertension",
          "rationale": "INCORRECT: This is part of the client's past medical history. While relevant to why he is on sertraline, it is not an acute finding that contraindicates the medication's administration at this moment. Focusing on the history distracts from the immediate clinical presentation.",
          "isCorrect": false,
          "score": 0
        },
        {
          "option": "lives in a rural community with limited primary care access",
          "rationale": "INCORRECT: This is a Social Determinant of Health (SDOH) that provides context for how the polypharmacy may have occurred (fragmented care), but it is not a direct physiological finding that mandates withholding the medication. It is important for long-term care planning but not the immediate safety concern.",
          "isCorrect": false,
          "score": 0
        },
        {
          "option": "was recently started on a new medication for migraines via a telehealth visit two days ago.",
          "rationale": "INCORRECT: This is a crucial piece of the puzzle for determining the etiology (the new medication is likely sumatriptan, a triptan). However, the instruction is to highlight the *findings* (symptoms), not the historical cause. While important for understanding the context, it does not directly indicate the need to withhold the medication based on the patient's current condition.",
          "isCorrect": false,
          "score": 0
        }
      ]
    }
  },
  "clinicalPearls": "*   **Serotonin Syndrome Triad:** Remember the triad of altered mental status, autonomic instability, and neuromuscular hyperactivity when assessing patients on serotonergic medications.\n*   **Medication Reconciliation:** Thorough medication reconciliation is crucial, especially in patients receiving care from multiple providers or via telehealth, to identify potential drug interactions.\n*   **Early Recognition is Key:** Early recognition and intervention are critical in managing serotonin syndrome to prevent life-threatening complications.\n*   **Clonus Assessment:** When assessing for clonus, support the knee in a partially flexed position and sharply dorsiflex the foot. Sustained clonus (rhythmic beats) is a significant indicator of serotonin syndrome.\n*   **SBAR Communication:** When communicating with the healthcare provider, use the SBAR format to provide a concise and organized report.",
  "sentinelStatus": "healed_v2026_v8"
}